Sinovac signed agreement with Bio Farma Indonesia for COVID-19 vaccine cooperation
On Aug. 25, 2020, Sinovac Biotech announced it had signed two agreements in Hainan, China with PT Bio…
-
-
Telesis Bio Demonstrates Momentum Toward Mission of Building World’s First Vaccine Printer and Global Vaccine Network
On Aug. 25, 2020, Telesis Bio, creators of the world’s first fully automated system for high-throughput writing of…
-
How SARS-CoV-2 spread across greater Boston during pandemic’s first wave
On Aug. 25, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, the Massachusetts…
-
CytoDyn reached enrollment of 195 patients in its phase 3 trial for COVID-19 patients with severe-to-critical symptoms
On Aug. 25, 2020, CytoDyn announced the Company had reached the requisite number of enrolled patients in its…
-
Man in Hong Kong was the first confirmed case of Coronavirus reinfection
On Aug. 24, 2020, Hong Kong University researchers reported that a 33-year-old man in Hong Kong had been…
-
Genomic analysis revealed many animal species may be vulnerable to SARS-CoV-2 infection
On Aug. 24, 2020, humans are not the only species facing a potential threat from SARS-CoV-2, the novel…
-
Catalent signed agreement with AstraZeneca to expand manufacturing support for COVID-19 vaccine AZD1222
On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
-
Trevena announced initiation of TRV027 study in COVID-19 patients in collaboration with Imperial College London
On Aug. 24, 2020,Trevena announced that Imperial College London (ICL) had initiated a proof-of-concept study for TRV027 in…
-
172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility
On Aug. 23, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
-
JAMA reported on effect of remdesivir vs standard care on clinical status in patients with moderate COVID-19
On Aug. 21, 2020, JAMA reported that hospitalized patients with moderate COVID-19 randomized to a 5-day course of…
-
Failure to ‘Flatten the Curve’ may kill more people than we thought
On Aug. 21, 2020, research by the University of Minnesota and the University of Washington found that every…
-
GT Biopharma updated development of TriKE(TM) therapeutic for treatment of COVID-19 infection
On Aug. 20, 2020, GT Biopharma and Cytovance announced a collaboration agreement whereby Cytovance will providing drug development…
-
CDC data showed disproportionate COVID-19 impact in American Indian/Alaska Native populations
On Aug. 19, 2020, the U.S. Centers for Disease Control and Prevention (CDC) released a new study that…
-
Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofia SARS…
-
BioNexus KC awarded grant to improve COVID-19 outcomes for patients with underlying health conditions
On Aug. 19, 2018, BioNexus KC announced it had been awarded a $42,900 grant from the Health Forward…
-
Bio-Techne and Leica Biosystems are acceleratied disease research with RNAscope COVID-19 probes and the BOND RX
On Aug. 19, 2020, Bio-Techne in partnership with Leica Biosystems, announced the automation of RNAscope COVID-19 probes on…
-
Regeneron and Roche collaborate to significantly increase global supply of REGN-COV2 investigational antibody cocktail for COVID-19
On Aug. 19, 2020, Regeneron and Roche announced that they were joining forces in the fight against COVID-19…
-
JAMA reported on evaluation for SARS-CoV-2 in breast milk from infected women
On Aug. 19, 2020, JAMA reported that to date, SARS-CoV-2 has not been isolated from breast milk, and…
-
NIH imposed ‘outrageous’ conditions on resuming coronavirus grants
On Aug. 19, 2020, the National Institutes of Health (NIH) announced it was requiring a small nonprofit research…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Spike protein of the new corona virus is more flexible than expected
On Aug. 18, 2020, scientists from the Max Planck Institute for Biophysics, the Paul Ehrlich Institute, the European…
-
HKUMed researchers discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune response
On Aug. 18, 2020, researchers from HKU-Pasteur Research Pole at the School of Public Health, LKS Faculty of…
-
FDA issued Emergency Use Authorization to Yale School of Public Health for SalivaDirect method of saliva sample processing
On Aug. 15, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to…
-
AstraZeneca concluded agreement with the EC for supply of up to 400 million doses of AZD1222 COVID-19 vaccine
On Aug. 14, 2020, AstraZeneca concluded an agreement with the European Commission (EC) to supply up to 400…
-
2 in 5 schools around the world lacked basic handwashing facilities prior to COVID-19 pandemic
On Aug. 13, 2020, data from the World Health Organization/United Nations International Children’s Emergency Fund Joint Monitoring Programme…
-
Philips launched Rapid Equipment Deployment Kit to COVID-19 response
On Aug. 13, 2020, Royal Philips introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses,…
-
Dynavax announced grant to scale up CpG 1018 adjuvant capacity to support global COVID-19 response
On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…
-
Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate
On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…
-
Baxter obtained FDA Emergency Use Authorizations for HF20 set and ST set used in CRRT during Covid-19 pandemic
On Aug. 12, 2020, Baxter announced it had received Emergency Use Authorizations (EUAs) from the FDA for the…
-
Hologic launched validated pooling protocol for COVID-19 testing
On Aug. 11, 2020, Hologic announced that it has validated use of its Aptima® and Panther Fusion® molecular…
-
Bio-Techne announced new SARS-CoV-1/2 spike RBD LlaMABody recombinant antibody that blocks viral entry
On Aug. 11, 2020, Bio-Techne announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds…
